{
    "Trade/Device Name(s)": [
        "EL-tTG IgA/IgG",
        "EL-Glia IgA/IgG",
        "TheraTest EL-tTG IgA/IgG",
        "TheraTest EL-Glia IgA/IgG"
    ],
    "Submitter Information": "TheraTest Laboratories, Inc.",
    "510(k) Number": "K071692",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MVM",
        "MST"
    ],
    "Summary Letter Date": "October 01, 2007",
    "Summary Letter Received Date": "October 02, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "IgA anti-tissue transglutaminase",
        "IgG anti-tissue transglutaminase",
        "IgA anti-gliadin",
        "IgG anti-gliadin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "Semi-quantitative measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Test System"
    ],
    "Document Summary": "FDA 510(k) summary for TheraTest EL-tTG and EL-Glia IgA/IgG ELISA kits for semi-quantitative detection of anti-tTG and anti-gliadin antibodies in human serum",
    "Indications for Use Summary": "Intended to aid the diagnosis of patients with gluten sensitive enteropathies (celiac disease and dermatitis herpetiformis) by detecting IgA and IgG antibodies against tissue transglutaminase and gliadin in human serum, in conjunction with other clinical findings and laboratory tests",
    "fda_folder": "Immunology"
}